Although STAT3 and YAP have been reported to promote EMT, invasion and proliferation in various cancers [36,37], previous studies investigating STAT3 in SCLC have mainly focused on drug resistance and not EMT, invasion or tumor progression. This evidence concerns the gene STAT3 and cancer.